US EditionPublished • loading... • Updated
Dyne Therapeutics Appoints Brian Posner to its Board of Directors - Dyne Therapeutics (NASDAQ:DYN)
Summary by Benzinga
1 Articles
1 Articles
Dyne Therapeutics Appoints Brian Posner to its Board of Directors - Dyne Therapeutics (NASDAQ:DYN)
WALTHAM, Mass., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (NASDAQ:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the appointment of Brian Posner to its Board of Directors. Mr. Posner brings 35 years of executive, investment and board leadership expertise to the company. "Brian is joining our Board during a pivotal phase,…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
